Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-04-02 Sale | 2026-04-07 4:21 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | McLaughlin Melissa Chief Human Resources Officer | 3,910 | $325.92 | $1,274,343 | 9,443 (Direct) | View |
| 2026-03-04 Sale | 2026-03-06 4:13 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal EVP Chief R&D | 4,713 | $323.53 | $1,524,796 | 19,374 (Indirect Direct) | View |
| 2026-03-04 Sale | 2026-03-06 4:13 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Greenstreet Yvonne Chief Executive Officer | 2,933 | $323.08 | $947,581 | 96,102 (Indirect Direct) | View |
| 2026-03-04 Sale | 2026-03-06 4:12 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer | 2,468 | $323.08 | $797,351 | 61,862 (Indirect Direct) | View |
| 2026-03-04 Sale | 2026-03-06 4:12 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Tanguler Tolga EVP, Chief Commercial Officer | 2,309 | $323.08 | $745,984 | 34,297 (Direct) | View |
| 2026-03-04 Sale | 2026-03-06 4:11 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Fitzgerald Kevin Joseph CSO & EVP, Head of Research | 1,291 | $323.54 | $417,685 | 21,106 (Indirect Direct) | View |
| 2026-03-02 Sale | 2026-03-04 7:31 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer | 2,206 | $327.65 | $722,801 | 74,810 (Indirect Direct) | View |
| 2026-03-02 Sale | 2026-03-04 7:31 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal EVP Chief R&D | 3,492 | $323.63 | $1,130,131 | 34,567 (Indirect Direct) | View |
| 2026-03-02 Sale | 2026-03-04 7:30 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Fitzgerald Kevin Joseph CSO & EVP, Head of Research | 3,250 | $323.62 | $1,051,773 | 30,502 (Indirect Direct) | View |
| 2026-03-02 Sale | 2026-03-04 7:30 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Tanguler Tolga EVP, Chief Commercial Officer | 1,598 | $327.65 | $523,584 | 47,086 (Direct) | View |
| 2026-03-02 Sale | 2026-03-04 7:29 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Greenstreet Yvonne Chief Executive Officer | 6,799 | $327.65 | $2,227,698 | 240,206 (Indirect Direct) | View |
| 2026-02-27 Sale | 2026-03-02 4:08 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal EVP Chief R&D | 4,627 | $331.34 | $1,533,100 | 22,810 (Indirect Direct) | View |
| 2026-02-13 Sale | 2026-02-17 7:28 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal EVP Chief R&D | 2,242 | $310.08 | $695,201 | 25,529 (Indirect Direct) | View |
| 2026-02-13 Sale | 2026-02-17 7:27 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Greenstreet Yvonne Chief Executive Officer | 6,958 | $310.08 | $2,157,542 | 86,069 (Indirect Direct) | View |
| 2026-02-13 Sale | 2026-02-17 7:27 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Tanguler Tolga EVP, Chief Commercial Officer | 1,959 | $310.08 | $607,448 | 31,769 (Direct) | View |
| 2026-02-13 Sale | 2026-02-17 7:26 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Fitzgerald Kevin Joseph CSO & EVP, Head of Research | 4,000 | $321.24 | $1,284,980 | 21,801 (Indirect Direct) | View |
| 2026-02-13 Sale | 2026-02-17 7:26 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer | 2,242 | $310.08 | $695,201 | 59,859 (Indirect Direct) | View |
| 2026-01-12 Sale | 2026-01-14 4:23 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal EVP Chief R&D | 1,510 | $362.87 | $547,929 | 23,192 (Indirect Direct) | View |
| 2026-01-12 Sale | 2026-01-14 4:23 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Greenstreet Yvonne Chief Executive Officer | 9,577 | $362.86 | $3,475,157 | 78,818 (Indirect Direct) | View |
| 2026-01-12 Sale | 2026-01-14 4:22 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer | 2,780 | $362.87 | $1,008,766 | 57,522 (Indirect Direct) | View |
| 2026-01-12 Sale | 2026-01-14 4:22 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Tanguler Tolga EVP, Chief Commercial Officer | 1,510 | $362.87 | $547,927 | 29,728 (Direct) | View |
| 2026-01-12 Sale | 2026-01-14 4:21 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Fitzgerald Kevin Joseph CSO & EVP, Head of Research | 3,800 | $367.37 | $1,395,992 | 21,801 (Indirect Direct) | View |
| 2025-11-17 Sale | 2025-11-19 4:05 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Fitzgerald Kevin Joseph CSO & EVP, Head of Research | 12,128 | $452.18 | $5,483,990 | 22,640 (Indirect Direct) | View |
| 2025-11-12 Sale | 2025-11-14 4:13 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Greenstreet Yvonne Chief Executive Officer | 25,650 | $452.75 | $11,613,003 | 75,816 (Indirect Direct) | View |
| 2025-10-02 Sale | 2025-10-03 5:14 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer | 3,821 | $452.05 | $1,727,284 | 54,109 (Indirect Direct) | View |
| 2025-10-02 Sale | 2025-10-03 5:14 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Greenstreet Yvonne Chief Executive Officer | 8,924 | $452.05 | $4,034,085 | 65,816 (Indirect Direct) | View |
| 2025-10-02 Sale | 2025-10-03 5:14 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Tanguler Tolga EVP, Chief Commercial Officer | 1,405 | $452.05 | $635,126 | 27,438 (Direct) | View |
| 2025-10-02 Sale | 2025-10-03 5:13 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Fitzgerald Kevin Joseph CSO & EVP, Head of Research | 2,441 | $452.05 | $1,103,451 | 25,768 (Indirect Direct) | View |
| 2025-10-02 Sale | 2025-10-03 5:12 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal EVP Chief R&D | 5,959 | $451.76 | $2,692,062 | 20,902 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
Ownership | 2026-04-07 4:16 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | McLaughlin Melissa Chief Human Resources Officer | 0 | $0 | 16,920 (Direct) | View |
| 2026-03-02 Option Award | 2026-03-04 7:31 pm | N/A 2036-03-02 | ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer | 15,249 | $0 | 74,810 (Direct) | View |
| 2026-03-02 Option Award | 2026-03-04 7:31 pm | N/A 2036-03-02 | ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal EVP Chief R&D | 15,249 | $0 | 34,567 (Direct) | View |
| 2026-03-02 Option Award | 2026-03-04 7:30 pm | N/A 2036-03-02 | ALNYLAM PHARMACEUTICALS INC. | ALNY | Fitzgerald Kevin Joseph CSO & EVP, Head of Research | 11,793 | $0 | 30,502 (Direct) | View |
| 2026-03-02 Option Award | 2026-03-04 7:30 pm | N/A 2036-03-02 | ALNYLAM PHARMACEUTICALS INC. | ALNY | Tanguler Tolga EVP, Chief Commercial Officer | 15,249 | $0 | 47,086 (Direct) | View |
| 2026-03-02 Option Award | 2026-03-04 7:29 pm | N/A 2036-03-02 | ALNYLAM PHARMACEUTICALS INC. | ALNY | SUPRAN BRYAN EVP, CLO and Secretary | 4,920 | $0 | 17,946 (Direct) | View |
| 2026-03-02 Option Award | 2026-03-04 7:29 pm | N/A 2036-03-02 | ALNYLAM PHARMACEUTICALS INC. | ALNY | Greenstreet Yvonne Chief Executive Officer | 155,015 | $0 | 240,206 (Direct) | View |
| 2026-02-27 Exercise | 2026-03-02 4:10 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Greenstreet Yvonne Chief Executive Officer | 5,921 | $0 | 91,990 (Direct) | View |
| 2026-02-27 Exercise | 2026-03-02 4:09 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer | 1,908 | $0 | 61,767 (Direct) | View |
| 2026-02-27 Exercise | 2026-03-02 4:09 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Tanguler Tolga EVP, Chief Commercial Officer | 1,666 | $0 | 33,435 (Direct) | View |
| 2026-02-27 Exercise | 2026-03-02 4:08 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal EVP Chief R&D | 1,908 | $0 | 22,810 (Direct) | View |
| 2026-02-23 Option Award | 2026-02-25 4:17 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Fitzgerald Kevin Joseph CSO & EVP, Head of Research | 158 | $0 | 21,959 (Direct) | View |
| 2026-02-12 Option Award | 2026-02-17 7:28 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal EVP Chief R&D | 4,579 | $0 | 25,529 (Direct) | View |
| 2026-02-12 Option Award | 2026-02-17 7:27 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Greenstreet Yvonne Chief Executive Officer | 14,209 | $0 | 86,069 (Direct) | View |
| 2026-02-12 Option Award | 2026-02-17 7:27 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Tanguler Tolga EVP, Chief Commercial Officer | 4,000 | $0 | 31,769 (Direct) | View |
| 2026-02-12 Option Award | 2026-02-17 7:26 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Fitzgerald Kevin Joseph CSO & EVP, Head of Research | 4,000 | $0 | 21,801 (Direct) | View |
| 2026-02-12 Option Award | 2026-02-17 7:26 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer | 4,579 | $0 | 59,859 (Direct) | View |
| 2026-01-11 Option Award | 2026-01-14 4:23 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal EVP Chief R&D | 3,800 | $0 | 23,192 (Direct) | View |
| 2026-01-11 Option Award | 2026-01-14 4:23 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Greenstreet Yvonne Chief Executive Officer | 19,003 | $0 | 78,818 (Direct) | View |
| 2026-01-11 Option Award | 2026-01-14 4:22 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer | 6,193 | $0 | 57,522 (Direct) | View |
| 2026-01-11 Option Award | 2026-01-14 4:22 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Tanguler Tolga EVP, Chief Commercial Officer | 3,800 | $0 | 29,728 (Direct) | View |
| 2026-01-11 Option Award | 2026-01-14 4:21 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Fitzgerald Kevin Joseph CSO & EVP, Head of Research | 3,800 | $0 | 21,801 (Direct) | View |
| 2026-01-05 Option Award | 2026-01-07 4:17 pm | N/A 2036-01-05 | ALNYLAM PHARMACEUTICALS INC. | ALNY | Arbuckle Stuart A Director | 3,279 | $0 | 3,279 (Direct) | View |
| 2025-11-26 Exercise | 2025-12-01 4:10 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Greenstreet Yvonne Chief Executive Officer | 839 | $119.13 | 97,533 (Direct) | View |
| 2025-11-26 Exercise | 2025-12-01 4:10 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Greenstreet Yvonne Chief Executive Officer | 847 | $118.05 | 97,533 (Direct) | View |
| 2025-11-26 Exercise | 2025-12-01 4:10 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Greenstreet Yvonne Chief Executive Officer | 659 | $151.59 | 97,533 (Direct) | View |
| 2025-11-26 Exercise | 2025-12-01 4:10 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Greenstreet Yvonne Chief Executive Officer | 2,352 | $85 | 97,533 (Direct) | View |
| 2025-11-26 Tax Withholding | 2025-12-01 4:10 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Greenstreet Yvonne Chief Executive Officer | 1,121 | $445.12 | 97,533 (Direct) | View |
| 2025-11-26 Exercise | 2025-12-01 4:10 pm | N/A 2029-02-27 | ALNYLAM PHARMACEUTICALS INC. | ALNY | Greenstreet Yvonne Chief Executive Officer | 4,697 | $0 | 97,533 (Direct) | View |
| 2025-11-17 Exercise | 2025-11-19 4:05 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Fitzgerald Kevin Joseph CSO & EVP, Head of Research | 8,161 | $119.13 | 22,640 (Direct) | View |
| 2025-11-17 Exercise | 2025-11-19 4:05 pm | N/A 2028-03-01 | ALNYLAM PHARMACEUTICALS INC. | ALNY | Fitzgerald Kevin Joseph CSO & EVP, Head of Research | 8,161 | $0 | 22,640 (Direct) | View |
| 2025-11-12 Exercise | 2025-11-14 4:13 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Greenstreet Yvonne Chief Executive Officer | 25,000 | $119.13 | 75,816 (Direct) | View |
| 2025-11-12 Exercise | 2025-11-14 4:13 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Greenstreet Yvonne Chief Executive Officer | 650 | $42.22 | 75,816 (Direct) | View |
| 2025-11-12 Exercise | 2025-11-14 4:13 pm | 2019-08-06 2026-12-20 | ALNYLAM PHARMACEUTICALS INC. | ALNY | Greenstreet Yvonne Chief Executive Officer | 25,650 | $0 | 75,816 (Direct) | View |
| 2025-10-01 Option Award | 2025-10-03 5:15 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | SUPRAN BRYAN EVP, CLO and Secretary | 13,026 | $0 | 13,026 (Direct) | View |
| 2025-10-01 Option Award | 2025-10-03 5:14 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer | 7,752 | $0 | 54,109 (Direct) | View |
| 2025-10-01 Option Award | 2025-10-03 5:14 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Greenstreet Yvonne Chief Executive Officer | 18,112 | $0 | 65,816 (Direct) | View |
| 2025-10-01 Option Award | 2025-10-03 5:14 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Tanguler Tolga EVP, Chief Commercial Officer | 2,851 | $0 | 27,438 (Direct) | View |
| 2025-10-01 Option Award | 2025-10-03 5:13 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Fitzgerald Kevin Joseph CSO & EVP, Head of Research | 4,953 | $0 | 25,768 (Direct) | View |
| 2025-10-01 Option Award | 2025-10-03 5:12 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal EVP Chief R&D | 5,959 | $0 | 20,902 (Direct) | View |